NCT00000937View on ClinicalTrials.gov

Study and Treatment of Post Lyme Disease (STOP-LD)

PHASE3CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2005

Conditions

Lyme Disease

Interventions

DRUG

Antibiotics

Trial Locations (1)

117948121

Lauren Krupp, Stony Brook

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000937 - Study and Treatment of Post Lyme Disease (STOP-LD) | Biotech Hunter | Biotech Hunter